Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.08 - $809.55 $12 - $123,051
152 New
152 $0
Q1 2022

May 16, 2022

SELL
$0.38 - $1.07 $26 - $74
-70 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$1.03 - $2.48 $1,498 - $3,608
-1,455 Reduced 95.41%
70 $0
Q3 2021

Nov 15, 2021

BUY
$2.14 - $4.95 $3,263 - $7,548
1,525 New
1,525 $3,000

Others Institutions Holding JAGX

About Jaguar Health, Inc.


  • Ticker JAGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 119,861,000
  • Market Cap $133M
  • Description
  • Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...
More about JAGX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.